步長製藥(603858.SH):宮瘤消膠囊及消乳散結膠囊獲得哈薩克斯坦註冊證書
格隆匯5月19日丨步長製藥(603858.SH)公佈,近日,山東步長製藥股份有限公司全資子公司山東步長神州製藥有限公司收到哈薩克斯坦衞生部核准簽發的關於宮瘤消膠囊及消乳散結膠囊的保健品註冊證書。
宮瘤消膠囊功能主治為:活血化瘀,軟堅散結。用於子宮肌瘤屬氣滯血瘀證,證見:月經量多,夾有大小血塊,經期延長,或有腹痛,舌暗紅,或邊有紫點、瘀斑,脈細弦或細澀。
宮瘤消膠囊為公司獨家品種,2021年度營業收入為2141.36萬元,佔公司營業收入的0.14%,2022年1-3月營業收入為536.32萬元,佔公司營業收入的0.17%。
消乳散結膠囊功能主治為:疏肝解鬱,化痰散結,活血止痛。用於肝鬱氣滯,痰瘀凝聚所致的乳腺增生,乳房脹痛。
消乳散結膠囊為公司獨家品種,2021年度營業收入為9477.35萬元,佔公司營業收入的0.60%,2022年1-3月營業收入為3046.01萬元,佔公司營業收入的0.95%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.